PA
MZTI

PharVision Advisers’s The Marzetti Company MZTI Stock Holding History

PharVision Advisers’s Portfolio MZTI Stock Details MZTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,111
Closed -$365K – 862
2025
Q3 		$365K Buy
+2,111
New +$379K 0.21% 117

Other funds holding MZTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $16.2B AUM 17.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PharVision Advisers's MZTI Position: Q4 2025 in Review

PharVision Advisers sold out of The Marzetti Company (MZTI) in Q4 2025, closing a stake of 2,111 shares — an estimated $365K sold.

PharVision Advisers first reported a position in MZTI in Q3 2025 and held it in 1 quarter. The position peaked at $365K in Q3 2025. 343 funds tracked by Wall St. Rank hold MZTI as of Q4 2025.

  • PharVision Advisers reported no remaining The Marzetti Company position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 2,111 The Marzetti Company shares in Q4 2025, an estimated $365K.
  • PharVision Advisers first reported a position in The Marzetti Company in Q3 2025 and held it in 1 quarter.
  • PharVision Advisers's The Marzetti Company position peaked at $365K in Q3 2025.
  • 343 funds tracked by Wall St. Rank held The Marzetti Company as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.